Bassett Hargrove Investment Counsel’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$889K Sell
8,640
-200
-2% -$21.6K 1.49% 29
2023
Q2
$980K Buy
8,840
+70
+0.8% +$7.95K 1.84% 25
2023
Q1
$933K Sell
8,770
-70
-0.8% -$7.56K 1.63% 26
2022
Q4
$980K Sell
8,840
-129
-1% -$13.2K 1.84% 25
2022
Q3
$772K Buy
+8,969
New +$801K 1.57% 29
2022
Q1
$792K Sell
9,649
-74
-0.8% -$5.83K 1.21% 33
2021
Q4
$745K Sell
9,723
-25
-0.3% -$1.99K 1.07% 32
2021
Q3
$758K Hold
9,748
1.13% 34
2021
Q2
$758K Buy
+9,748
New +$725K 1.13% 34

Other funds holding MRK

Bassett Hargrove Investment Counsel's MRK Position: Q3 2023 in Review

Bassett Hargrove Investment Counsel reduced its Merck (MRK) stake by 2.3% in Q3 2023, selling an estimated $21.6K and leaving 8,640 shares worth $889K. The position accounts for 1.49% of the portfolio, ranked #29.

Bassett Hargrove Investment Counsel first reported a position in MRK in Q2 2021 and has held it in 9 quarters since. The position peaked at $980K in Q2 2023. 3,214 funds tracked by Wall St. Rank hold MRK as of Q3 2023.

  • Bassett Hargrove Investment Counsel held 8,640 shares of Merck worth $889K as of Q3 2023.
  • Bassett Hargrove Investment Counsel sold 200 Merck shares in Q3 2023, an estimated $21.6K.
  • Merck made up 1.49% of Bassett Hargrove Investment Counsel's portfolio in Q3 2023, its #29 holding.
  • Bassett Hargrove Investment Counsel first reported a position in Merck in Q2 2021 and has held it in 9 quarters since.
  • Bassett Hargrove Investment Counsel's Merck position peaked at $980K in Q2 2023.
  • 3,214 funds tracked by Wall St. Rank held Merck as of Q3 2023.

Based on Bassett Hargrove Investment Counsel's 13F filing for Q3 2023, filed 26 Oct 2023.